Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation

doi:10.4254/wjh.v18.i1.111722

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

(53)

(31)

(0)

(682)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jan 27, 2026; 18(1): 111722
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111722

Full Size Figure Download Figure

Figure 2 Distribution of high (orange bars) and low modified Charlson comorbidity index patients (blue bars) across various etiology of liver disease in our study. HCC: Hepatocellular carcinoma; MASH: Metabolic dysfunction-associated steatohepatitis; mCCI: Modified Charlson comorbidity index.

Citation: Rajan G, Sam AF, Rajakumar A, Jothimani D, Rela M. Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation. World J Hepatol 2026; 18(1): 111722
URL: https://www.wjgnet.com/1948-5182/full/v18/i1/111722.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i1.111722

Rajan G, Sam AF, Rajakumar A, Jothimani D, Rela M. Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation. World J Hepatol 2026; 18(1): 111722 [PMID: 41640957 DOI: 10.4254/wjh.v18.i1.111722]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.